For Christmas, Duck on Duck on Duck
Mile End's Antony Nassif makes Duck Two Ways, Smoke Char Siu & Confit.
Terminally Ill Man Takes On Marathon Towing Oxygen Tank
Training for any long distance race is tough but tackling 26 point two miles I'll just be glad it's over that's downright grueling. He gets overlooked give me now about it. Three years ago I can barely make it in the Carrasco from from the partridge. Evans Wilson has pulmonary fibrosis and
EpiPen Maker Mylan Settles With DOJ for $465M Over Medicaid Allegations
The embattled pharmaceutical company Mylan said Friday evening that it had agreed to settle a case with the Department of Justice for $465 million after it was accused of over-billing the government for its EpiPen product. The company, which has been embroiled in a scandal over the cost of the
Senators Call for Justice Department Probe of Mylan , the EpiPen Manufacturer
Three members of the Senate Judiciary Committee, in a letter sent today to Attorney General Loretta Lynch , have asked the Justice Department to investigate whether EpiPen manufacturer Mylan incorrectly classified its lifesaving product to save millions of dollars in required payments to states.
Allergists Warn Against Using 'DIY EpiPen'
The rising cost of EpiPens has driven some families to search for ways to save money on the expensive devices. Online tutorials that teach people how to make their own EpiPens have been watched by tens of thousands, but experts warn that using a homemade injector could be dangerous. While these
New Developments in NBA Star Derrick Rose's Sexual Assault Case
The "GMA" team of insiders analyze some of the biggest stories trending this morning.
Mylan CEO, Lawmakers Trade Barbs Over EpiPen Pricing
Mylan Pharmaceuticals CEO Heather Bresch defended her company’s pricing of its popular EpiPen during a hearing before the U.S. House Committee on Oversight and Government Reform this afternoon. "Price and access exist in a balance, and we believe we have struck that balance," Bresch said,
Head of Pharmaceutical Company Mylan Grilled Over Cost Increase of EpiPens
The price of the lifesaving allergy shot has risen more than 500 percent since 2007.
Mylan CEO Defends EpiPen Price Hike to Lawmakers
Mylan Pharmaceuticals CEO Heather Bresch defended her company's decision to increase the price of the EpiPen during a hearing held by the House Committee on Oversight and Government Reform this afternoon.